Reconstruction Methods and Complications of Esophagogastrostomy and Jejunal Interposition in Proximal Gastrectomy for Gastric Cancer: A Meta-Analysis.

(<em>A</em>bstractText>Proximal gastrectomy is used for the therapy of major gastric most cancers by open or laparoscopic surgical procedure in the higher third of the abdomen. Esophagogastrostomy (EG) or jejunal interposition (JI) is broadly used in varied reconstruction strategies after proximal gastrectomy.

We carried out a meta-analysis of EG and JI for therapy of gastric most cancers.</<em>A</em>bstractText><p><div><b>Materials and Methods</b></div><em>A</em> <em>search</em> of PubMed, Embase, MEDLINE, J-ST<em>A</em>GE, and Cochrane Library recognized retrospective collection on EG and JI.

Weight imply variations (WMDs), odds ratios (ORs), and 95% confidence intervals (CIs) had been used to investigate the operation-related knowledge and postoperative problems. Heterogeneity was evaluated by the <i>I</i><sup>2</sup> take a look at, and potential publication bias was assessed with Egger regression exams and sensitivity evaluation.</p><p><div><b>Results</b></div>Eight research had been chosen, and 496 sufferers had been included.

EG group advantages had been 44.81 min shorter working time (<i>P</i> < 0.001), 56.58 mL much less blood loss (<i>P</i> = 0.03), and 7.four days shorter hospital keep time (<i>P</i> < 0.001) than the JI group. Between the 2 teams, there was no vital distinction in anastomotic leakage; in any other case, the EG group had a decrease threat of anastomotic stenosis (OR = 0.44, 95%CI = 0.20 to 0.97, <i>P</i> = 0.04), decrease threat of intestinal obstruction (OR = 0.07, 95%CI = 0.01 to 0.43, <i>P</i> = 0.004), and greater threat of reflux esophagitis (OR = 2.47, 95%CI = 1.07 to five.72, <i>P</i> = 0.03).</p>(<em>A</em>bstractText>The outcomes of our research indicated that EG has vital benefits throughout the perioperative interval and in short-term outcomes in comparison with JI.</<em>A</em>bstractText>

Reconstruction Methods and Complications of Esophagogastrostomy and Jejunal Interposition in Proximal Gastrectomy for Gastric Cancer: A Meta-Analysis.
Reconstruction Methods and Complications of Esophagogastrostomy and Jejunal Interposition in Proximal Gastrectomy for Gastric Cancer: A Meta-Analysis.

Identifying medicine with disease-modifying potential in Parkinson’s illness utilizing synthetic intelligence and pharmacoepidemiology.

The purpose of the research was to evaluate the feasibility of an strategy combining computational strategies and pharmacoepidemiology to determine probably disease-modifying medicine in Parkinson’s illness (PD).

We used a two-step strategy; (a) computational technique utilizing synthetic intelligence to rank 620 medicine in the Ontario Drug Benefit formulary based mostly on their predicted means to inhibit alpha-synucleinaggregation, a pathogenic hallmark of PD; and (b) case-control research utilizing administrative databases in Ontario, Canada.

EIF4A1 Antibody

ABD7256 100 ug
EUR 525.6

EIF4A1 siRNA

20-abx915189
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EIF4A1 siRNA

20-abx915190
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EIF4A1 Antibody

AF7554 200ul
EUR 540

EIF4A1 Antibody

DF7256 200ul
EUR 420

EIF4A1 Antibody

1-CSB-PA007550ESR1HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EIF4A1. Recognizes EIF4A1 from Human, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200

EIF4A1 Antibody

RQ6048 100 ug
EUR 419
Description: Eukaryotic initiation factor 4A-I is a protein that in humans is encoded by the EIF4A1 gene. It is mapped to 17p13.1. EIF4A1 has been shown to interact with EIF4E and eukaryotic translation initiation factor 4 gamma.

EIF4A1 Antibody

RQ6226 100 ug
EUR 419
Description: Eukaryotic initiation factor 4A-I is a protein that in humans is encoded by the EIF4A1 gene. It is mapped to 17p13.1. EIF4A1 has been shown to interact with EIF4E and eukaryotic translation initiation factor 4 gamma.

EIF4A1 Antibody

RQ6594 100ug
EUR 419
Description: Eukaryotic initiation factor 4A-I is a protein that in humans is encoded by the EIF4A1 gene. It is mapped to 17p13.1. EIF4A1 has been shown to interact with EIF4E and eukaryotic translation initiation factor 4 gamma.

Anti-EIF4A1 Antibody

A03922-3 100ug/vial
EUR 400.8

eIF4A1 Rabbit mAb

A11584-100ul 100 ul
EUR 492

eIF4A1 Rabbit mAb

A11584-200ul 200 ul
EUR 685.2

eIF4A1 Rabbit mAb

A11584-20ul 20 ul
EUR 265.2

eIF4A1 Rabbit mAb

A11584-50ul 50 ul
EUR 344.4

EIF4A1 Blocking Peptide

33R-9207 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EIF4A1 antibody, catalog no. 70R-4514

EIF4A1 Rabbit pAb

A5294-100ul 100 ul
EUR 369.6

EIF4A1 Rabbit pAb

A5294-200ul 200 ul
EUR 550.8

EIF4A1 Rabbit pAb

A5294-20ul 20 ul
EUR 219.6

EIF4A1 Rabbit pAb

A5294-50ul 50 ul
EUR 267.6

eIF4A1 Monoclonal Antibody

ABM40136-003ml 0.03ml
EUR 189.6
Description: A monoclonal antibody for detection of eIF4A1 from Human, Mouse, Rat. This eIF4A1 antibody is for WB, IHC-P, IF. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide

eIF4A1 Monoclonal Antibody

ABM40136-01ml 0.1ml
EUR 346.8
Description: A monoclonal antibody for detection of eIF4A1 from Human, Mouse, Rat. This eIF4A1 antibody is for WB, IHC-P, IF. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide

eIF4A1 Monoclonal Antibody

ABM40136-02ml 0.2ml
EUR 496.8
Description: A monoclonal antibody for detection of eIF4A1 from Human, Mouse, Rat. This eIF4A1 antibody is for WB, IHC-P, IF. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide

EIF4A1 Blocking Peptide

AF7554-BP 1mg
EUR 234

eIF4A1 Mouse mAb

BF9011 100 ug
EUR 525.6

EIF4A1 Blocking Peptide

DF7256-BP 1mg
EUR 234

EIF4A1 Conjugated Antibody

C32748 100ul
EUR 476.4

EIF4A1 cloning plasmid

CSB-CL007550HU-10ug 10ug
EUR 541.2
Description: A cloning plasmid for the EIF4A1 gene.

eIF4A1 Monoclonal Antibody

EM1136-100ul 100ul
EUR 334.8
Description: A Mouse Monoclonal antibody against eIF4A1 from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF

eIF4A1 Monoclonal Antibody

EM1136-50ul 50ul
EUR 248.4
Description: A Mouse Monoclonal antibody against eIF4A1 from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF

anti-eIF4A1 (M8)

LF-MA20426 100 ug
EUR 424.8
Description: Mouse monoclonal to eIF4A1

Anti-eIF4A1 antibody

STJ97038 200 µl
EUR 236.4
Description: eIF4A1 is a protein encoded by the EIF4A1 gene which is approximately 46,1 kDa. eIF4A1 is localised to the cytoplasm and cell membrane. It is involved in viral mRNA translation, deadenylation-dependent mRNA decay, regulation of lipid metabolism and insulin signalling-generic cascades. It is an ATP-dependent RNA helicase that is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. eIF4A1 is expressed in the liver, lung, nervous system, pancreas and skin. STJ97038 was developed from clone M8 and was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. The antibody detects endogenous eIF4A1 protein.

Anti-EIF4A1 antibody

STJ27247 100 µl
EUR 332.4

pOTB7-EIF4A1 Plasmid

PVT15919 2 ug
EUR 390

EIF4A1 (Phospho-Tyr48) Antibody

12919-100ul 100ul
EUR 302.4

EIF4A1 (Phospho-Tyr48) Antibody

12919-50ul 50ul
EUR 224.4

eIF4A1 Mouse Monoclonal Antibody

38072-100ul 100ul
EUR 302.4

eIF4A1 Mouse Monoclonal Antibody

38072-50ul 50ul
EUR 224.4

eIF4A1 recombinant monoclonal antibody

A5837 100ul X 3
EUR 714
Description: A recombinant monoclonal antibody from rabbit against human eIF4A1 for WB, IF,ELISA

Human EIF4A1 shRNA Plasmid

20-abx951364
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Phospho-EIF4A1 (Tyr48) Antibody

AF7054 200ul
EUR 540

Mouse EIF4A1 shRNA Plasmid

20-abx970144
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

EIF4A1 Recombinant Protein (Human)

RP010438 100 ug Ask for price

EIF4A1 Recombinant Protein (Rat)

RP199379 100 ug Ask for price

EIF4A1 Recombinant Protein (Mouse)

RP131306 100 ug Ask for price

EIF4A1 Recombinant Protein (Mouse)

RP131309 100 ug Ask for price

EIF4A1/2/3 Antibody

RQ5520 100 ug
EUR 419

Anti-EIF4A1/2/3 Antibody

A03922-2 100ug/vial
EUR 400.8

Phospho-EIF4A1(Tyr48) Blocking Peptide

AF7054-BP 1mg
EUR 234

Eif4a1 ORF Vector (Rat) (pORF)

ORF066461 1.0 ug DNA
EUR 607.2

EIF4A1 ORF Vector (Human) (pORF)

ORF003480 1.0 ug DNA
EUR 114

Eif4a1 ORF Vector (Mouse) (pORF)

ORF043770 1.0 ug DNA
EUR 607.2

Eif4a1 ORF Vector (Mouse) (pORF)

ORF043771 1.0 ug DNA
EUR 607.2

EIF4A1 (Phospho-Tyr48) Polyclonal Conjugated Antibody

C12919 100ul
EUR 476.4

Eif4a1 sgRNA CRISPR Lentivector set (Rat)

K7567401 3 x 1.0 ug
EUR 406.8

EIF4A1 sgRNA CRISPR Lentivector set (Human)

K0669001 3 x 1.0 ug
EUR 406.8

Eif4a1 sgRNA CRISPR Lentivector set (Mouse)

K4652401 3 x 1.0 ug
EUR 406.8

Eukaryotic Translation Initiation Factor 4A1 (EIF4A1) Antibody

20-abx159486
  • EUR 326.40
  • EUR 276.00
  • 100 ug
  • 50 ug

Eukaryotic Translation Initiation Factor 4A1 (eIF4A1) Antibody

20-abx141720
  • EUR 444.00
  • EUR 727.20
  • EUR 360.00
  • 100 ul
  • 200 ul
  • 50 ul

Eukaryotic Translation Initiation Factor 4A1 (EIF4A1) Antibody

abx145206-100ug 100 ug
EUR 469.2

Eukaryotic Translation Initiation Factor 4A1 (EIF4A1) Antibody

20-abx004044
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Eukaryotic Translation Initiation Factor 4A1 (EIF4A1) Antibody

abx033274-400ul 400 ul
EUR 627.6

Eukaryotic Translation Initiation Factor 4A1 (EIF4A1) Antibody

abx033274-80l 80 µl
EUR 343.2

Eukaryotic Translation Initiation Factor 4A1 (EIF4A1) Antibody

20-abx322752
  • EUR 360.00
  • EUR 292.80
  • 100 ul
  • 50 ul

Eukaryotic Translation Initiation Factor 4A1 (EIF4A1) Antibody

20-abx176330
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Eif4a1 sgRNA CRISPR Lentivector (Rat) (Target 1)

K7567402 1.0 ug DNA
EUR 184.8

Eif4a1 sgRNA CRISPR Lentivector (Rat) (Target 2)

K7567403 1.0 ug DNA
EUR 184.8

Eif4a1 sgRNA CRISPR Lentivector (Rat) (Target 3)

K7567404 1.0 ug DNA
EUR 184.8

EIF4A1 sgRNA CRISPR Lentivector (Human) (Target 1)

K0669002 1.0 ug DNA
EUR 184.8

EIF4A1 sgRNA CRISPR Lentivector (Human) (Target 2)

K0669003 1.0 ug DNA
EUR 184.8

EIF4A1 sgRNA CRISPR Lentivector (Human) (Target 3)

K0669004 1.0 ug DNA
EUR 184.8

Eif4a1 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4652402 1.0 ug DNA
EUR 184.8

Eif4a1 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4652403 1.0 ug DNA
EUR 184.8

Eif4a1 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4652404 1.0 ug DNA
EUR 184.8

EIF4A1 Protein Vector (Human) (pPB-C-His)

PV013917 500 ng
EUR 394.8

EIF4A1 Protein Vector (Human) (pPB-N-His)

PV013918 500 ng
EUR 394.8

EIF4A1 Protein Vector (Human) (pPM-C-HA)

PV013919 500 ng
EUR 394.8

EIF4A1 Protein Vector (Human) (pPM-C-His)

PV013920 500 ng
EUR 394.8

EIF4A1 Protein Vector (Mouse) (pPB-C-His)

PV175078 500 ng
EUR 723.6

EIF4A1 Protein Vector (Mouse) (pPB-N-His)

PV175079 500 ng
EUR 723.6

EIF4A1 Protein Vector (Mouse) (pPM-C-HA)

PV175080 500 ng
EUR 723.6

EIF4A1 Protein Vector (Mouse) (pPM-C-His)

PV175081 500 ng
EUR 723.6

EIF4A1 Protein Vector (Mouse) (pPB-C-His)

PV175082 500 ng
EUR 723.6

EIF4A1 Protein Vector (Mouse) (pPB-N-His)

PV175083 500 ng
EUR 723.6

EIF4A1 Protein Vector (Mouse) (pPM-C-HA)

PV175084 500 ng
EUR 723.6

EIF4A1 Protein Vector (Mouse) (pPM-C-His)

PV175085 500 ng
EUR 723.6

Recombinant Eukaryotic Translation Initiation Factor 4A1 (EIF4A1)

4-RPF009Hu01
  • EUR 281.28
  • EUR 199.20
  • EUR 724.80
  • EUR 321.60
  • EUR 523.20
  • EUR 264.00
  • EUR 1632.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Eukaryotic Translation Initiation Factor 4A1 expressed in: E.coli

EIF4A1 3'UTR Luciferase Stable Cell Line

TU006752 1.0 ml
EUR 1672.8

Eif4a1 3'UTR GFP Stable Cell Line

TU253893 1.0 ml Ask for price

Eif4a1 3'UTR Luciferase Stable Cell Line

TU105726 1.0 ml Ask for price

EIF4A1 3'UTR GFP Stable Cell Line

TU056752 1.0 ml
EUR 1672.8

Eif4a1 3'UTR Luciferase Stable Cell Line

TU203893 1.0 ml Ask for price

Eif4a1 3'UTR GFP Stable Cell Line

TU155726 1.0 ml Ask for price

EIF4A1 Protein Vector (Rat) (pPB-C-His)

PV265842 500 ng
EUR 723.6

EIF4A1 Protein Vector (Rat) (pPB-N-His)

PV265843 500 ng
EUR 723.6

EIF4A1 Protein Vector (Rat) (pPM-C-HA)

PV265844 500 ng
EUR 723.6

EIF4A1 Protein Vector (Rat) (pPM-C-His)

PV265845 500 ng
EUR 723.6

Human Eukaryotic Translation Initiation Factor 4A1 (EIF4A1) Protein

20-abx650629
  • EUR 393.60
  • EUR 243.60
  • EUR 994.80
  • EUR 460.80
  • EUR 309.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

EIF4A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV639235 1.0 ug DNA
EUR 818.4

EIF4A1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV639239 1.0 ug DNA
EUR 818.4

EIF4A1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV639240 1.0 ug DNA
EUR 818.4

Mouse Eukaryotic initiation factor 4A- I, Eif4a1 ELISA KIT

ELI-27327m 96 Tests
EUR 1038

Human Eukaryotic initiation factor 4A- I, EIF4A1 ELISA KIT

ELI-43379h 96 Tests
EUR 988.8

Bovine Eukaryotic initiation factor 4A- I, EIF4A1 ELISA KIT

ELI-30971b 96 Tests
EUR 1113.6

Rabbit Eukaryotic initiation factor 4A- I, EIF4A1 ELISA KIT

ELI-13199Ra 96 Tests
EUR 1113.6

Eif4a1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7567405 3 x 1.0 ug
EUR 451.2

EIF4A1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0669005 3 x 1.0 ug
EUR 451.2

Eif4a1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K4652405 3 x 1.0 ug
EUR 451.2

Eif4a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K7567406 1.0 ug DNA
EUR 200.4

Eif4a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K7567407 1.0 ug DNA
EUR 200.4

Eif4a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K7567408 1.0 ug DNA
EUR 200.4

EIF4A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV639236 1.0 ug DNA
EUR 818.4

EIF4A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV639237 1.0 ug DNA
EUR 888

EIF4A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV639238 1.0 ug DNA
EUR 888

EIF4A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0669006 1.0 ug DNA
EUR 200.4

EIF4A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0669007 1.0 ug DNA
EUR 200.4

EIF4A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0669008 1.0 ug DNA
EUR 200.4

Eif4a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K4652406 1.0 ug DNA
EUR 200.4

Eif4a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K4652407 1.0 ug DNA
EUR 200.4

Eif4a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K4652408 1.0 ug DNA
EUR 200.4

Persons aged 70-110 years with incident PD from April 2002-March 2013. Controls had been randomly chosen from individuals with no earlier analysis of PD. A complete of 15 of the highest 50 medicine had been deemed possible for pharmacoepidemiologic evaluation, of which seven had been considerably related to incident PD after adjustment, with 5 of these seven related to a decreased odds of PD.

Methylxanthine medicine pentoxifylline (OR, 0.72; 95% CI, 0.59-0.89) and theophylline (OR, 0.77; 95% CI, 0.66-0.91), and the corticosteroid dexamethasone (OR, 0.72; 95% CI, 0.61-0.85) had been related to decreased odds of PD.Our findings reveal the feasibility of this strategy to focus the search for disease-modifying medicine. Corticosteroids and methylxanthines must be additional investigated as potential disease-modifyingdrugs in PD.

Geef een antwoord

Het e-mailadres wordt niet gepubliceerd.